Early and Aggressive Initiation of Insulin Therapy for Type 2 Diabetes: What Is the Evidence?

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinical Diabetes

• Publication date

  2009-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/diaclin.27.2.60
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Standards of Medical Care in Diabetes—2012

  2011cited by this paper
• Standards of medical care in diabetes--2007.

  2009cited by this paper
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes

  2009cited by this paper
• Comparison of insulin analogue regimens in people with type 2 diabetes mellitus in the PREFER Study: a randomized controlled trial

  2009cited by this paper
• Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

  2009cited by this paper
• Once‐daily insulin detemir is comparable to once‐daily insulin glargine in providing glycaemic control over 24 h in patients with type 2 diabetes: a double‐blind, randomized, crossover study

  2009cited by this paper
• Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2009cited by this paper
• Standards of Medical Care in Diabetes—2009

  2009cited by this paper
• Importance of Postprandial Glucose Levels as a Target for Glycemic Control in Type 2 Diabetes

  2009cited by this paper
• Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2009cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008cited by this paper
• Initiating Insulin Therapy in Type 2 Diabetes: Benefits of Insulin Analogs and Insulin Pens

  2008cited by this paper
• Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

  2008cited by this paper
• A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

  2008cited by this paper
• Reduced Weight Gain with Insulin Detemir Compared to NPH Insulin Is Not Explained by a Reduction in Hypoglycemia

  2008cited by this paper
• Glycaemic control and adverse events in patients with type 2 diabetes treated with metformin + sulphonylurea: a meta‐analysis

  2008cited by this paper
• Effects of insulin vs. glibenclamide in recently diagnosed patients with type 2 diabetes: a 4‐year follow‐up

  2008cited by this paper
• Less weight gain and hypoglycaemia with once‐daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients—The PREDICTIVE™ BMI clinical trial 1

  2008cited by this paper
• Less weight gain and hypoglycaemia with once-daily insulin detemir than NPH insulin in intensification of insulin therapy in overweight Type 2 diabetes patients: the PREDICTIVE BMI clinical trial.

  2008cited by this paper
• Recognition and management of diabetic neuropathy.

  2007cited by this paper
• Delay Of Insulin Addition To Oral Combination Therapy Despite Inadequate Glycemic Control

  2007cited by this paper
• Potential roles of erythropoietin in the management of anaemia and other complications diabetes

  2007cited by this paper
• Insulin Detemir Results in Less Weight Gain than NPH Insulin When Used in Basal-Bolus Therapy for Type 2 Diabetes Mellitus, and this Advantage Increases with Baseline Body Mass Index

  2007cited by this paper
• The endothelium and vascular inflammation in diabetes

  2007cited by this paper
• Towards peakless, reproducible and long‐acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies

  2007cited by this paper
• Secondary failure of glycemic control for patients adding thiazolidinedione or sulfonylurea therapy to a metformin regimen.

  2007cited by this paper
• Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal‐only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14‐week follow‐up data from PREDICTIVE™

  2007cited by this paper
• The usage of a simplified self‐titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes – results of the randomized, controlled PREDICTIVE™ 303 study

  2007cited by this paper
• The Washington Manual Of Medical Therapeutics

  2007cited by this paper
• A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naïve People With Type 2 Diabetes

  2007cited by this paper
• The Switch from Sulfonylurea to Preprandial Short- Acting Insulin Analog Substitution Has an Immediate and Comprehensive β-Cell Protective Effect in Patients with Type 2 Diabetes Mellitus

  2006cited by this paper
• Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.

  2006cited by this paper
• Attainment of glycaemic goals in type 2 diabetes with once‐, twice‐, or thrice‐daily dosing with biphasic insulin aspart 70/30 (The 1‐2‐3 study)

  2006cited by this paper
• Islet beta cell failure in type 2 diabetes.

  2006cited by this paper
• Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride.

  2006cited by this paper
• Glycemic control continues to deteriorate after sulfonylureas are added to metformin among patients with type 2 diabetes.

  2005cited by this paper
• Lower within‐subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes

  2005cited by this paper
• The pathobiology of diabetic complications: a unifying mechanism.

  2005cited by this paper
• Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study.

  2005cited by this paper
• Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.

  2005cited by this paper
• Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.

  2005cited by this paper
• Insulin detemir and insulin aspart: a promising basal-bolus regimen for type 2 diabetes.

  2004cited by this paper
• Beta-cell failure in the pathogenesis of type 2 diabetes mellitus

  2004cited by this paper
• Diabetes Self-Management Education Core Outcomes Measures

  2003cited by this paper
• Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin.

  2003cited by this paper
• Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

  2002cited by this paper
• Less nocturnal hypoglycemia and better post-dinner glucose control with bedtime insulin glargine compared with bedtime NPH insulin during insulin combination therapy in type 2 diabetes. HOE 901/3002 Study Group.

  2000cited by this paper
• Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia.

  1999cited by this paper
• Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper

• Factors Associated with Glycemic Control among Type 2 Diabetic Patients Attending Primary Health Care Centers in Qatar, a Cross-Sectional Study

  2020cites this paper
• Effectiveness and Safety of Physician-Led Versus Patient-Led Titration of Insulin Glargine in Indian Patients with Type 2 Diabetes Mellitus: A Subanalysis of the Asian Treat to Target Lantus Study (ATLAS)

  2019cites this paper
• Mean HbA1c Comparison among Diabetic Subgroups Treated with Oral Agents alone, Insulin alone and Combination of Both

  2018cites this paper
• A STUDY ON ASSESSMENT OF GLYCEMIC CONTROL OF ORAL HYPOGLYCEMIC DRUGS AND INSULIN IN TYPE 2 DIABETES MELLITUS PATIENTS

  2018cites this paper
• The Efficacity of Abelmoschus esculentus Fruit on Insulin Control in Diabetic Male Wistar Rats

  2018cites this paper
• Heterogeneity of change in state affect following insulin therapy initiation in type 2 diabetic patients

  2017cites this paper
• Efficacy of oral versus insulin therapy for newly diagnosed diabetes in low-income settings.

  2017influential citation
• Cadm2 regulates body weight and energy homeostasis in mice

  2017cites this paper
• Clinical safety of insulin detemir in patients with Type 2 diabetes in the Gulf countries: The multicenter, noninterventional, open-label LevSafe study

  2016cites this paper
• Hypoglycemic agents and potential anti-inflammatory activity

  2016cites this paper
• The Management of Hyperglycaemia and Dyslipidaemia in an In-Patient Setting : forum

  2016cites this paper
• اثر میوه گیاه بامیه (Abelmoschus esculentus) بر کنترل قند و انسولین در رت های نر نژاد ویستار دیابتی شده

  2016cites this paper
• Dipeptidyl peptidase-4 inhibitors as add-on therapy to insulin: rationale and evidences

  2016cites this paper
• Differential effects of insulin sensitization and insulin provision treatment strategies on concentrations of circulating adipokines in patients with diabetes and coronary artery disease in the BARI 2D trial

  2016cites this paper
• Improved Treatment Satisfaction and Self-reported Health Status after Introduction of Basal-Supported Oral Therapy Using Insulin Glargine in Patients with Type 2 Diabetes: Sub-Analysis of ALOHA2 Study

  2015cites this paper
• The Rising cost of Diabetes: Tips for prevention

  2015cites this paper
• Similar efficacy and safety of LY2963016 insulin glargine and insulin glargine (Lantus®) in patients with type 2 diabetes who were insulin‐naïve or previously treated with insulin glargine: a randomized, double‐blind controlled trial (the ELEMENT 2 study)

  2015cites this paper
• Examining drug utilisation patterns and optimal treatment pathways of antidiabetic medications

  2015cites this paper
• A COMPARISON OF THE EFFECTS OF COMBINATION VILDAGLIPTIN AND METFORMIN WITH VILDAGLIPTIN, METFORMIN MONOTHERAPY IN INDIAN PATIENTS WITH TYPE 2 DIABETES MELLITUS

  2014cites this paper
• INITIATE STUDY: Insulin versus Oral Hypoglycemic Agent as Initial Therapy for Newly Diagnosed Diabetes Mellitus Type 2: A Systematic Review and Meta-Analysis

  2014cites this paper
• Type 2 diabetes mellitus in elderly institutionalized patients.

  2014cites this paper
• Predictive factors for the efficacy of switch to oral hypoglycemic agents in Japanese type 2 diabetic patients with intensive insulin therapy temporarily introduced.

  2014cites this paper
• Diabetes mellitus tipo 2 en el paciente anciano institucionalizado

  2014cites this paper
• Switching from basal or basal-bolus insulin to biphasic insulin aspart 30: Results from the Indian cohort of the A1 chieve study

  2014cites this paper
• [Timely commencement of insulin in type 2 diabetes: benefits and risks].

  2014cites this paper
• Exploring insulin analogue safety and effectiveness in a Maghrebian cohort with type 2 diabetes: results from the A₁chieve study.

  2013cites this paper
• Safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes: results from the ASEAN cohort of the A₁chieve study.

  2013influential citation
• Safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: results from the Filipino cohort of the A₁chieve study.

  2013cites this paper
• Potent and Prolonged Hypoglycemic Activity of an Oral Insulin – Tat Mixture in Diabetic Mice

  2013cites this paper
• Efficacy and safety of combination therapy with vildagliptin and metformin versus metformin up-titration in Chinese patients with type 2 diabetes mellitus: study design and rationale of the vision study

  2013cites this paper
• Clinical Experience with Insulin Detemir in Patients with Type 2 Diabetes from the Near East Countries

  2013cites this paper
• Significance of observational data on type 2 diabetes management in North Africa.

  2013cites this paper
• Clinical safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: results from the Indonesian cohort of the A₁chieve study.

  2013cites this paper
• Safety and effectiveness of insulin detemir in type 2 diabetes: results from the ASEAN cohort of the A₁chieve study.

  2013influential citation
• Initiating or switching to biphasic insulin aspart 30 in type 2 diabetes patients from Algeria: a sub-analysis of the A₁chieve study.

  2013influential citation
• Switch from biphasic human insulin 30 to biphasic insulin aspart 30 in Pakistani subjects.

  2013cites this paper
• Safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes : Results from theASEAN cohort of the A 1 chieve study

  2013cites this paper
• Safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30 : Results from the Filipino cohort of the A 1 chieve study

  2013cites this paper
• Insulin initiation in the community

  2013cites this paper
• Sécurité et efficacité de l’insuline détémir en initiation chez les patients algériens diabétiques de type 2: Résultats de l’étude A1chieve

  2013cites this paper
• Early Insulin Initiation—A Review of the Literature and Case Studies

  2012cites this paper
• Allergy to human insulin and specific immunotherapy with glargine; case report with review of literature

  2012cites this paper
• Insulin: a new era for an old hormone.

  2010cites this paper
• International Journal of Nephrology and Renovascular Disease Dovepress

  year unknowncites this paper